Increased RAD51 levels may contribute to tumorigenesis, and accordingly we found that elevated RAD51 levels are associated with young age at breast cancer onset, higher tumor grade and characteristics of aggressive tumors (e.g. lack of hormone receptor expression and HER2 amplification). This evidence concerns the gene ERBB2 and neoplasm.